Sign In
Buy FBLG
$1.07
+0.0200 (+1.90%)
At Close: Jun 03, 2026
FibroBiologics Presents Preclinical Data at the 2024 Keystone Symposia for Systemic Autoimmune and Autoinflammatory Diseases
09:31am, Tuesday, 13'th Feb 2024
HOUSTON , Feb. 13, 2024 /PRNewswire/ -- FibroBiologics (Nasdaq: FBLG) ("FibroBiologics"), a clinical-stage biotechnology company focused on the development of therapeutics and potential cures for chr
FibroBiologics Announces Three United States Patents for Fibroblast Technology
09:31am, Thursday, 08'th Feb 2024
HOUSTON , Feb. 8, 2024 /PRNewswire/ -- FibroBiologics (Nasdaq: FBLG) ("FibroBiologics"), a clinical-stage biotechnology company focused on the development of therapeutics and potential cures for chron
FibroBiologics Announces Three Japanese Patents on Fibroblast Technology
09:31am, Tuesday, 06'th Feb 2024
HOUSTON , Feb. 6, 2024 /PRNewswire/ -- FibroBiologics (Nasdaq: FBLG) ("FibroBiologics"), a clinical-stage biotechnology company focused on the development of therapeutics and potential cures for chron
U.S. IPO Weekly Recap: Amer Sports' Billion-Dollar U.S. IPO Leads A Week Of Large Listings
06:16am, Sunday, 04'th Feb 2024
Sports equipment and apparel maker Amer Sports priced below the range to raise $1.3 billion at a $6.4 billion market cap. CNS disorder biotech Alto Neuroscience priced its upsized IPO at the top of th
FibroBiologics Announces Direct Listing on NASDAQ Under the Stock Ticker FBLG
10:00am, Wednesday, 31'st Jan 2024
HOUSTON , Jan. 31, 2024 /PRNewswire/ -- FibroBiologics, Inc. (NASDAQ: FBLG) ("FibroBiologics"), a clinical-stage biotechnology company focused on the development of therapeutics and potential cures f
U.S. IPO Weekly Recap: Reinsurance And CAR T Therapies Lead A 3 IPO Week
11:15am, Sunday, 12'th Nov 2023
Three IPOs and two SPACs debuted this week, while the pipeline got a boost from a flurry of initial filings. Oncology biotech CARGO Therapeutics priced at the bottom of the range to raise $281 million
